Star Wars Roleplay: Chaos

Register a free account today to become a member! Once signed in, you'll be able to participate on this site by adding your own topics and posts, as well as connect with other members through your own private inbox!

Approved Tech XFT-11 “Clearline” Intravenous Detox Patch

Status
Not open for further replies.
Manufacturer: XeroMed, XeroCorp Technologies
Type: Biotech
Market Status: Open Market
Production: Mass-Produced
Weight: Very Light
Size: Small
SPECIAL FEATURES
  • Transdermal patch with internal toxin filters and biosensors
  • Detects and neutralizes organic poisons, narcotics, and combat drugs
  • Programmable chemical neutralization profiles
  • Auto-injection system for stabilizers or preloaded counteragents
  • Low-profile and adhesive for quick application
STRENGTHS
  • Provides immediate bloodstream detoxification in the field
  • Programmable to counteract specific toxins or drugs in advance
  • Lightweight and easily carried or worn for constant readiness
WEAKNESSES
  • Single-use; must be replaced or recharged after activation
  • Ineffective against synthetic nanotoxins or exotic biochemical agents
  • May trigger withdrawal shock in users addicted to filtered compounds
DESCRIPTION
XFT-11 "Clearline" is a single-use IV filtration patch developed by XeroCorp Technologies for frontline soldiers, covert operatives, and high-risk medical deployments. When applied to a major vein area (typically forearm or neck), the patch activates a biosensor suite that immediately scans the user's bloodstream for chemical anomalies. If toxins, stimulants, or biological agents are detected, the patch activates its microfiltration membrane and begins purging contaminants while stabilizing core vitals.

Clearline units are commonly pre-programmed with neutralization routines for known combat drugs or battlefield toxins. More advanced users customize their patches with personal counteragent profiles uploaded through external medical systems. Once activated, the patch can complete a full detox cycle in under three minutes.

The system is highly effective for standard poisons, performance enhancers, or overdose situations, but less reliable against synthetic or mutagenic compounds engineered to bypass biological filtration. While openly available on the market, many high-tier Clearline variants remain proprietary to XeroCorp's special operations arm, particularly those with embedded compound-response AI or encrypted chemical libraries.
 


Out Of Character Info


Intent: To provide a compact, programmable IV patch capable of rapidly filtering toxins, narcotics, and biochem contaminants from a user’s bloodstream
Permissions: N/A

Technical Information


Affiliation: XeroMed, XeroCorp Technologies, Open-Market Users, Independent Medical Providers, Private Security Forces
Modular: No
Material: To provide a compact, programmable IV patch capable of rapidly filtering toxins, narcotics, and biochem contaminants from a user’s bloodstream
Status
Not open for further replies.

Users who are viewing this thread

Top Bottom